Korea Otsuka Pharmaceuticals

Korea Otsuka Pharmaceutical is a prominent healthcare company in South Korea and a strategic subsidiary of Japan's Otsuka Pharmaceutical. Founded in 1982, the company has evolved from a joint venture into a comprehensive pharmaceutical entity encompassing R&D, manufacturing, and commercialization. It operates a world-class manufacturing facility in Hyangnam, which serves as a global supply hub for the Otsuka Group, exporting products to over 20 countries. The company's therapeutic focus includes central nervous system disorders, cardiovascular diseases, gastroenterology, and nephrology. Key products in its portfolio include the antipsychotic Abilify, the antiplatelet agent Pletaal, and the aquaretic Samsca. Korea Otsuka is recognized for its commitment to local innovation and high-quality production standards within the global Otsuka network.